Actively Recruiting

Phase Not Applicable
Age: 18Years - 85Years
All Genders
NCT06848140

Using Non-invasive Brain Stimulation to Treat Word Finding Difficulty in Chronic Traumatic Brain Injury

Led by Beth Israel Deaconess Medical Center · Updated on 2025-10-21

24

Participants Needed

1

Research Sites

134 weeks

Total Duration

On this page

Sponsors

B

Beth Israel Deaconess Medical Center

Lead Sponsor

N

National Institute on Deafness and Other Communication Disorders (NIDCD)

Collaborating Sponsor

AI-Summary

What this Trial Is About

The purpose of this study is to learn more about how brain stimulation affects word finding problems in people who have a traumatic brain injury (TBI). The type of brain stimulation used is called transcranial direct current stimulation (tDCS). tDCS delivers low levels of electric current to the brain and high definition tDCS (HD-tDCS) delivers the current with multiple electrodes on the scalp. This current is delivered with HD-tDCS to parts of the brain that may help with remembering things. The investigators hope that this can help to improve word finding and memory problems in people with TBI.

CONDITIONS

Official Title

Using Non-invasive Brain Stimulation to Treat Word Finding Difficulty in Chronic Traumatic Brain Injury

Who Can Participate

Age: 18Years - 85Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age between 18 and 85 years
  • Fluent in speaking and reading English
  • Able to provide informed consent
  • Had a traumatic brain injury at least one year prior to enrollment not related to military experience
  • Has confirmed verbal retrieval difficulties measured by interview questions
Not Eligible

You will not qualify if you...

  • History of major or active neurological conditions such as stroke, epilepsy, brain tumor, dementia, or recent seizures within the past year
  • History of major or active cardiovascular conditions like heart arrhythmia, heart failure, or heart attack
  • Current substance use disorder
  • History of major psychiatric disorders including schizophrenia or bipolar disorder
  • Severe depression at enrollment (BDI-II score 29 or higher) or psychiatric emergency visits or hospitalization within past 6 months
  • Current sensory impairments (blindness, deafness) or physical impairments that affect testing
  • Contraindications for tDCS or MRI
  • Cannot be left alone for more than 8 hours
  • Not verbally communicative
  • Currently receiving speech or cognitive therapy and unwilling to stop during the study
  • Unable to understand or provide consent
  • Unable to travel to BIDMC's Berenson-Allen Center
  • Pregnancy

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Beth Israel Deaconess Medical Center

Boston, Massachusetts, United States, 02215

Actively Recruiting

Loading map...

Research Team

I

Iris Hall, BS

CONTACT

H

Hsueh-Sheng Chiang, MD, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

TRIPLE

Allocation

RANDOMIZED

Model

CROSSOVER

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here